Comparison of endoscopic ultrasound-guided fine-needle aspiration and biopsy with 22-gauge and 25-gauge needles for the "precision medicine" of pancreatic cancer: A retrospective study
- PMID: 29901627
- PMCID: PMC6023851
- DOI: 10.1097/MD.0000000000011096
Comparison of endoscopic ultrasound-guided fine-needle aspiration and biopsy with 22-gauge and 25-gauge needles for the "precision medicine" of pancreatic cancer: A retrospective study
Abstract
We compared the sample volume of endoscopic ultrasound-guided fine-needle aspiration and biopsy (EUS-FNAB) specimens obtained by 22-gauge (22G) and 25-gauge (25G) needles, and the accuracy rate.This was a retrospective study in a single tertiary referral center. We investigated 153 patients with pancreatic ductal adenocarcinoma (PDAC) who underwent diagnostic EUS-FNAB before neoadjuvant gemcitabine-based chemoradiotherapy between October 2006 and November 2015. We performed immunohistochemical (IHC) analysis of human equilibrative nucleoside transporter 1 using the remnant cell blocks following pathological PDAC diagnosis. We compared the sampling rate, accuracy rate, and success rate of IHC analysis between 22G and 25G.There were 70 patients in the 22G group and 83 patients in the 25G group. The overall sampling rates on cytology and histology were 100% and 98.0%, respectively. The sampling rate did not differ between the 22G and 25G groups. The overall diagnostic accuracy rates on cytology and histology were 94.8% and 79.7%, respectively. The accuracy rates of 22G and 25G groups on cytology were 94.3% and 95.2%, respectively, whereas those on histology were 80.0% and 79.5%, respectively. The diagnostic accuracy on cytology and histology did not differ significantly between the 22G and 25G groups. Of 153 histology specimens, 69.3% of those with PDAC provided sufficient samples for IHC analysis. The success rate of IHC analysis did not differ significantly between the 22G (67.1%) and 25G (71.1%) groups (P = .60).Both 22G and 25G provided a high diagnostic yield with equivalent accuracy rates on histology. EUS-FNAB specimens obtained using 22G or 25G can be equally adequate for IHC analysis and may be suitable for diagnostic examination. Further investigations such as EUS-FNAB needle design and novel cell block preparation are needed to obtain adequate samples for use in "precision medicine."
Conflict of interest statement
The authors have no funding and conflicts of interest to disclose.
Similar articles
-
Endoscopic ultrasound-guided sampling of solid pancreatic masses: 22-gauge aspiration versus 25-gauge biopsy needles.BMC Gastroenterol. 2015 Sep 29;15:122. doi: 10.1186/s12876-015-0352-9. BMC Gastroenterol. 2015. PMID: 26419845 Free PMC article.
-
Endoscopic Ultrasound-guided Sampling of Solid Pancreatic Lesions: A Comparative Analysis of 25 Gauge Versus 22 Gauge Core Biopsy Needles.Anticancer Res. 2020 Oct;40(10):5845-5851. doi: 10.21873/anticanres.14603. Anticancer Res. 2020. PMID: 32988914
-
A comparison between 25-gauge and 22-gauge Franseen needles for endoscopic ultrasound-guided sampling of pancreatic and peripancreatic masses: a randomized non-inferiority study.Endoscopy. 2021 Nov;53(11):1122-1129. doi: 10.1055/a-1369-8610. Epub 2021 Mar 2. Endoscopy. 2021. PMID: 33652495 Clinical Trial.
-
A comparison of the efficiency of 22G versus 25G needles in EUS-FNA for solid pancreatic mass assessment: A systematic review and meta-analysis.Clinics (Sao Paulo). 2018;73:e261. doi: 10.6061/clinics/2018/e261. Epub 2018 Feb 15. Clinics (Sao Paulo). 2018. PMID: 29451621 Free PMC article.
-
EUS - Fine- Needle Aspiration Biopsy (FNAB) in the Diagnosis of Pancreatic Adenocarcinoma: A Review.Rom J Intern Med. 2016 Jan-Mar;54(1):24-30. doi: 10.1515/rjim-2016-0002. Rom J Intern Med. 2016. PMID: 27141567 Review.
Cited by
-
Methods to increase the diagnostic efficiency of endoscopic ultrasound-guided fine-needle aspiration for solid pancreatic lesions: An updated review.World J Gastrointest Endosc. 2024 Mar 16;16(3):117-125. doi: 10.4253/wjge.v16.i3.117. World J Gastrointest Endosc. 2024. PMID: 38577648 Free PMC article. Review.
-
Evaluation of MMR Status and PD-L1 Expression Using Specimens Obtained by EUS-FNB in Patients with Pancreatic Ductal Adenocarcinoma (PDAC).Diagnostics (Basel). 2022 Jan 25;12(2):294. doi: 10.3390/diagnostics12020294. Diagnostics (Basel). 2022. PMID: 35204385 Free PMC article.
-
The relationship between the PD-L1 expression of surgically resected and fine-needle aspiration specimens for patients with pancreatic cancer.J Gastroenterol. 2019 Nov;54(11):1019-1028. doi: 10.1007/s00535-019-01586-6. Epub 2019 Apr 29. J Gastroenterol. 2019. PMID: 31032528
-
Comparison of Endoscopic Ultrasound-Guided Fine Needle Aspiration with 19-Gauge and 22-Gauge Needles for Solid Pancreatic Lesions.Int J Gen Med. 2021 Dec 30;14:10439-10446. doi: 10.2147/IJGM.S342525. eCollection 2021. Int J Gen Med. 2021. PMID: 35002300 Free PMC article.
-
Evaluation of Needles in Endoscopic Ultrasound-Guided Tissue Acquisition of Pancreatic Cancer for Genetic Yield and Quality.Cureus. 2024 Sep 2;16(9):e68431. doi: 10.7759/cureus.68431. eCollection 2024 Sep. Cureus. 2024. PMID: 39360054 Free PMC article.
References
-
- Moore MJ, Goldstein D, Hamm J, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2007;25:1960–6. - PubMed
-
- Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011;364:1817–25. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical